Streetbeat News

Revenues

GXO

GXO Logistics has reaffirmed its full-year 2024 guidance on a standalone basis and updated its guidance to account for the expected impact of the Wincanton acquisition. CEO Malcolm Wilson highlighted solid preliminary first quarter results and anticipates continued sequential organic growth throughout 2024.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 11:13 am

HCSG

Healthcare Services (HCSG) reaffirms its 2024 forecast for adjusted cash flow between $40M-$55M and expects Q2 revenue to be in the range of $420M-$430M, slightly below the consensus estimate of $430.417M.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 11:11 am

V

Visa Inc. (NYSE:V) shares rose in premarket trading after reporting Q2 2024 earnings of $2.51 per share, surpassing the consensus estimate of $2.44. Payments volume increased by 8%, and cross-border volume grew by 16% on a constant-dollar basis. Quarterly revenues were $8.775 billion, exceeding estimates of $8.627 billion. Visa expects low double-digit net revenue growth and high-end low double-digit EPS growth for Q3, with full-year 2024 expectations in the low double-digits for net revenue and low-teens for EPS growth.

Portfolio Pulse from Nabaparna Bhattacharya

April 24, 2024 | 11:10 am

RCI

Rogers Communications Inc. (RCI) reported a 28% year-over-year increase in Q1 revenue, reaching C$4.90 billion. However, its adjusted earnings per share (EPS) decreased to C$0.99 from C$1.09 YoY.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 11:05 am

TZOO

Travelzoo anticipates its revenue to grow year-over-year in Q2, though at a slower rate compared to 2023. The company's outlook suggests a positive trend in earnings, but with moderated growth expectations.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 11:05 am

ODFL

Old Dominion Freight Line (ODFL) reported Q1 2024 earnings of $1.34 per share, meeting analyst estimates, but missed revenue expectations with $1.460 billion against a forecast of $1.473 billion, marking a 1.25% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 11:01 am

BIIB

Biogen has reaffirmed its 2024 adjusted EPS guidance of $15.00-$16.00, indicating a 5% growth from 2023, aligning with a consensus of $15.48. The company anticipates a low- to mid-single digit percentage decline in total revenue compared to 2023 but expects its core pharmaceutical revenue to remain stable. Additionally, Biogen projects a low-double digit percentage growth in operating income and a mid-single digit percentage improvement in operating margin.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:53 am

MAG

MAG Silver announced that its Juanicipio project processed 325,684 tonnes of ore in the first quarter. This operational update highlights the project's ongoing development and potential impact on MAG Silver's production capabilities.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:52 am

SPY

TSLA

U.S. stock markets closed higher, driven by strong earnings and interest in growth stocks, with Tesla's stock surging 6% after hours despite lower-than-expected revenue. The S&P Global composite PMI dropped, while new home sales rose. Asian and European markets also saw gains, with Japan's Nikkei 225 leading. Commodities saw mixed results, and the U.S. dollar index rose.

Portfolio Pulse from Akanksha Bakshi

April 24, 2024 | 10:47 am

BSX

Boston Scientific projects its Q2 2024 net sales to grow by about 10.5%-12.5% year-over-year on a reported basis, and around 10%-12% on an organic basis.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:39 am